These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19372851)

  • 1. Considerations in the design of randomized controlled trials evaluating the optimal time to initiate antiretroviral therapy in previously untreated HIV-1-infected patients.
    Babiker AG; Gibb DM
    Curr Opin HIV AIDS; 2006 Nov; 1(6):488-94. PubMed ID: 19372851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.
    Pai NP; Lawrence J; Reingold AL; Tulsky JP
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006148. PubMed ID: 16856117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early versus deferred antiretroviral therapy in children in low-income and middle-income countries.
    Puthanakit T; Bunupuradah T
    Curr Opin HIV AIDS; 2010 Jan; 5(1):12-7. PubMed ID: 20046143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronutrient supplementation in adults with HIV infection.
    Visser ME; Durao S; Sinclair D; Irlam JH; Siegfried N
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003650. PubMed ID: 28518221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment interruption in children with HIV infection.
    Green H; Gibb DM
    Curr Opin HIV AIDS; 2007 Jan; 2(1):62-8. PubMed ID: 19372867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
    ; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
    Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How have guidelines on when to start antiretroviral therapy affected survival of people living with HIV infection?
    Rodger AJ; Sabin CA
    Curr Opin HIV AIDS; 2016 Sep; 11(5):487-491. PubMed ID: 27465878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.
    Pai NP; Tulsky JP; Lawrence J; Colford JM; Reingold AL
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005482. PubMed ID: 16235406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
    Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
    Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers].
    Ramos JT; de José MI; Polo R; Fortuny C; Mellado MJ; Muñoz-Fernández MA; Beceiro J; Bertrán JM; Calvo C; Chamorro L; Ciria L; Guillén S; González-Montero R; González-Tomé MI; Gurbindo MD; Martín-Fontelos P; Martínez-Pérez J; Moreno D; Muñoz-Almagro MC; Mur A; Navarro ML; Otero C; Rojo P; Rubio B; Saavedra J; ; ; ;
    Enferm Infecc Microbiol Clin; 2005 May; 23(5):279-312. PubMed ID: 15899180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question.
    Eholié SP; Badje A; Kouame GM; N'takpe JB; Moh R; Danel C; Anglaret X
    AIDS Res Ther; 2016; 13():27. PubMed ID: 27462361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field.
    Wittkop L; Smith C; Fox Z; Sabin C; Richert L; Aboulker JP; Phillips A; Chêne G; Babiker A; Thiébaut R;
    Clin Trials; 2010 Feb; 7(1):19-35. PubMed ID: 20156955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.